Advanced search
Publication Cover
Pharmaceutical Biology Volume 57, 2019 - Issue 1
Submit an article Journal homepage
2,997
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Vitexin as an active ingredient in passion flower with potential as an agent for nicotine cessation: vitexin antagonism of the expression of nicotine locomotor sensitization in rats

Samantha BedellDepartment of Pharmaceutical Sciences, Campbell University College of Pharmacy & Health Sciences, Buies Creek, NC, USAORCID Iconhttp://orcid.org/0000-0002-3081-8490View further author information
ORCID Icon,
Jacob WellsDepartment of Pharmaceutical Sciences, Campbell University College of Pharmacy & Health Sciences, Buies Creek, NC, USAORCID Iconhttp://orcid.org/0000-0003-3947-0475View further author information
ORCID Icon,
Qinfeng LiuDepartment of Pharmaceutical Sciences, Campbell University College of Pharmacy & Health Sciences, Buies Creek, NC, USAORCID Iconhttp://orcid.org/0000-0001-7330-9445View further author information
ORCID Icon &
Chris BreivogelDepartment of Pharmaceutical Sciences, Campbell University College of Pharmacy & Health Sciences, Buies Creek, NC, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-5657-2735View further author information
ORCID Icon
Pages 8-12 | Received 23 Jun 2018, Accepted 12 Dec 2018, Published online: 01 Feb 2019

References

  • Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. 2001. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 26:363–367.
  • Benowitz NL. 1996. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol. 36:597–613.
  • Breivogel C, Jamerson B. 2012. Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats. Pharm Biol. 50:1310–1316.
  • Cahill K, Stevens S, Lancaster T. 2014. Pharmacological treatments for smoking cessation. JAMA. 311:193–194.
  • Dani JA, De Biasi M. 2001. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav. 70:439–446.
  • Dhawan K, Dhawan S, Sharma A. 2004. Passiflora: a review update. J Ethnopharmacol. 94:1–23.
  • Dhawan K, Kumar S, Sharma A. 2001. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol. 78:165–170.
  • Dhawan K, Kumar S, Sharma A. 2002. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata Linneaus: a comment on medicinal plants' standardization. J Altern Complement Med. 8:283–291.
  • DiFranza JR, Wellman RJ. 2007. Sensitization to nicotine: how the animal literature might inform future human research. Nicotine Tob Res. 9:9–20.
  • Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR. 2006. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 296:47–55.
  • Hostetler GL, Ralston RA, Schwartz SJ. 2017. Flavones: food sources, bioavailability, metabolism, and bioactivity. Adv Nutr. 8:423–435.
  • Kayir H, Goktalay G, Yildirim M, Uzbay TI. 2009. Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats. Synapse. 63:15–21.
  • Krenn L. 2002. [Passion flower (Passiflora incarnata L.)–a reliable herbal sedative]. Wien Med Wochenschr. 152:404–406. German.
  • Ksir C, Hakan RL, Kellar KJ. 1987. Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology (Berl.). 92:25–29.
  • Li Z, DiFranza JR, Wellman RJ, Kulkarni P, King JA. 2008. Imaging brain activation in nicotine-sensitized rats. Brain Res. 1199:91–99.
  • Moeller DW, Sun LS. 2010. Chemical and radioactive carcinogens in cigarettes: associated health impacts and responses of the tobacco industry, U.S. Congress, and federal regulatory agencies. Health Phys. 99:674–679.
  • Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. 2008. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg. 106:1728–1732.
  • Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. 2007. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med. 7:26.
  • Nemeth K, Plumb GW, Berrin JG, Juge N, Jacob R, Naim HY, Williamson G, Swallow DM, Kroon PA. 2003. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr. 42:29–42.
  • Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F. 1997. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J Ethnopharmacol. 57:11–20.
  • Wadgave U, Nagesh L. 2016. Nicotine replacement therapy: an overview. Int J Health Sci (Qassim). 10:425–435.
  • Werneke U, Turner T, Priebe S. 2006. Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry. 188:109–121.
  • Zaniewska M, McCreary AC, Stefański R, Przegaliński E, Filip M. 2008. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats. Synapse. 62:935–939.
  • Zanoli P, Avallone R, Baraldi M. 2000. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia. 71 (Suppl 1):S117–S123.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.